Document Detail

Cytoprotective effects of olive mill wastewater extract and its main constituent hydroxytyrosol in PC12 cells.
MedLine Citation:
PMID:  20600919     Owner:  NLM     Status:  MEDLINE    
Evidence from epidemiological studies indicates that adherence to diets rich in secondary plant metabolites, such as polyphenols and phenolic acids, possibly reduces the risk of age-dependent neurodegeneration and subsequent cognitive decline. Olive mill wastewater is particularly rich in the ortho-diphenol hydroxytyrosol (HT) that can be recovered with ad hoc techniques. In a previous study, we showed that hydroxytyrosol-rich olive mill wastewater extract protects dissociated brain cells not only in vitro but also ex vivo after subchronic oral administration of the extract to mice. As plant extracts often contain constituents with potentially confounding activities, our present study aimed to test in vitro whether HT at concentrations present in olive mill wastewater extract is able to protect PC12 cells with similar efficiency. Following a short-term exposure (30min) to the compounds of interest, cells were subjected to oxidative or nitrosative stress by adding either ferrous iron or sodium nitroprusside to the cell culture medium for 18h, respectively. Cytotoxicity was assessed by measuring MTT reduction, cellular ATP levels and mitochondrial membrane potential in the absence and presence of HT or HT-rich olive mill wastewater extract. The results we obtained mainly confirm our previous observation of promising cytoprotection of brain cells by HT-rich olive mill wastewater extract in different stressor paradigms. Furthermore, correlation analyses revealed that the observed cytoprotective effects in PC12 cells are likely due to HT present in the extract.
Sebastian Schaffer; Walter E Müller; Gunter P Eckert
Related Documents :
18588169 - Effects of ph and added metabolites on bioconversions by immobilized non-growing clostr...
1338569 - Insulin modulation of human apolipoprotein b mrna translation: studies in an in vitro c...
10840219 - Protease activity in fractionated blood cells of the vanadium accumulating ascidian pha...
16061299 - Degradation of aflatoxin b(1) by cell-free extracts of rhodococcus erythropolis and myc...
20170379 - Antioxidative and antiproliferative activities of different horsetail (equisetum arvens...
18576579 - A new immobilized cell system with protection against toxic solvents.
3335229 - Butyrate effect on nuclear proteins of two chinese hamster cell lines.
23536519 - Resveratrol inhibits proliferation, angiogenesis and induces apoptosis in colon cancer ...
8039979 - Perforating lichen nitidus.
Publication Detail:
Type:  Journal Article     Date:  2010-06-16
Journal Detail:
Title:  Pharmacological research : the official journal of the Italian Pharmacological Society     Volume:  62     ISSN:  1096-1186     ISO Abbreviation:  Pharmacol. Res.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-08-06     Completed Date:  2010-11-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8907422     Medline TA:  Pharmacol Res     Country:  England    
Other Details:
Languages:  eng     Pagination:  322-7     Citation Subset:  IM    
Copyright Information:
Copyright 2010 Elsevier Ltd. All rights reserved.
Institute of Pharmacology, Biocenter Niederursel, University of Frankfurt, Max-von-Laue Strasse 9, 60438 Frankfurt am Main, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antioxidants / pharmacology*
Cytoprotection / drug effects*
Iron / metabolism
Olea / chemistry*
Oxidative Stress
PC12 Cells
Phenylethyl Alcohol / analogs & derivatives*,  pharmacology
Plant Extracts / pharmacology*
Waste Disposal, Fluid*
Reg. No./Substance:
0/Antioxidants; 0/Plant Extracts; 10597-60-1/3,4-dihydroxyphenylethanol; 60-12-8/Phenylethyl Alcohol; 7439-89-6/Iron

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  NPY Y(1) receptors are involved in cardio-respiratory responses to intravenous injection of neuropep...
Next Document:  The genomic risk of somatic gene therapy.